BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 12161101)

  • 1. In vivo effect of rhGM-CSF And rhG-CSF on monocyte HLA-DR expression of septic neonates.
    Drossou-Agakidou V; Kanakoudi-Tsakalidou F; Sarafidis K; Tzimouli V; Taparkou A; Kremenopoulos G; Germenis A
    Cytokine; 2002 Jun; 18(5):260-5. PubMed ID: 12161101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of immunoparalysis by recombinant human granulocyte-macrophage colony-stimulating factor in patients with severe sepsis.
    Nierhaus A; Montag B; Timmler N; Frings DP; Gutensohn K; Jung R; Schneider CG; Pothmann W; Brassel AK; Schulte Am Esch J
    Intensive Care Med; 2003 Apr; 29(4):646-51. PubMed ID: 12595977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulocyte-macrophage colony-stimulating factor (GM-CSF) restores decreased monocyte HLA-DR expression after cardiopulmonary bypass.
    Börgermann J; Friedrich I; Scheubel R; Kuss O; Lendemans S; Silber RE; Kreuzfelder E; Flohé S
    Thorac Cardiovasc Surg; 2007 Feb; 55(1):24-31. PubMed ID: 17285470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is low monocyte HLA-DR expression helpful to predict outcome in severe sepsis?
    Perry SE; Mostafa SM; Wenstone R; Shenkin A; McLaughlin PJ
    Intensive Care Med; 2003 Aug; 29(8):1245-52. PubMed ID: 12774155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Administration of recombinant human granulocyte-colony stimulating factor to septic neonates induces neutrophilia and enhances the neutrophil respiratory burst and beta2 integrin expression. Results of a randomized controlled trial.
    Drossou-Agakidou V; Kanakoudi-Tsakalidou F; Sarafidis K; Taparkou A; Tzimouli V; Tsandali H; Kremenopoulos G
    Eur J Pediatr; 1998 Jul; 157(7):583-8. PubMed ID: 9686822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma.
    Lendemans S; Kreuzfelder E; Waydhas C; Schade FU; Flohé S
    Inflamm Res; 2007 Jan; 56(1):38-44. PubMed ID: 17334669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human granulocyte colony-stimulating factor may improve outcome attributable to neonatal sepsis complicated by neutropenia.
    Kocherlakota P; La Gamma EF
    Pediatrics; 1997 Jul; 100(1):E6. PubMed ID: 9200380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monocyte anergy is present in patients with severe acute pancreatitis and is significantly alleviated by granulocyte-macrophage colony-stimulating factor and interferon-gamma in vitro.
    Kylanpaa ML; Mentula P; Kemppainen E; Puolakkainen P; Aittomaki S; Silvennoinen O; Haapiainen R; Repo H
    Pancreas; 2005 Jul; 31(1):23-7. PubMed ID: 15968243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial.
    Meisel C; Schefold JC; Pschowski R; Baumann T; Hetzger K; Gregor J; Weber-Carstens S; Hasper D; Keh D; Zuckermann H; Reinke P; Volk HD
    Am J Respir Crit Care Med; 2009 Oct; 180(7):640-8. PubMed ID: 19590022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The in vitro effects of granulocyte and granulocyte-macrophage colony-stimulating factor on interleukin-3-dependent proliferation of human neonatal circulating progenitor cells.
    Bedford Russell AR; Davies EG; Gibson FM; Gordon-Smith EC
    Pediatr Res; 1995 May; 37(5):630-3. PubMed ID: 7541523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized trial of granulocyte-macrophage colony-stimulating factor in neonates with sepsis and neutropenia.
    Bilgin K; Yaramiş A; Haspolat K; Taş MA; Günbey S; Derman O
    Pediatrics; 2001 Jan; 107(1):36-41. PubMed ID: 11134431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric measurement of HLA-DR expression on circulating monocytes in healthy and sick neonates using monocyte negative selection.
    Kanakoudi-Tsakalidou F; Debonera F; Drossou-Agakidou V; Sarafidis K; Tzimouli V; Taparkou A; Kremenopoulos G
    Clin Exp Immunol; 2001 Mar; 123(3):402-7. PubMed ID: 11298126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte-macrophage colony-stimulating factor stimulates human monocyte accessory cell function.
    Smith PD; Lamerson CL; Wong HL; Wahl LM; Wahl SM
    J Immunol; 1990 May; 144(10):3829-34. PubMed ID: 2185314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monocyte HLA-DR expression as predictor of poor outcome in neonates with late onset neonatal sepsis.
    Genel F; Atlihan F; Ozsu E; Ozbek E
    J Infect; 2010 Mar; 60(3):224-8. PubMed ID: 20025903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of granulocyte-macrophage colony-stimulating factor on the immune response of circulating monocytes after severe trauma.
    Flohé S; Lendemans S; Selbach C; Waydhas C; Ackermann M; Schade FU; Kreuzfelder E
    Crit Care Med; 2003 Oct; 31(10):2462-9. PubMed ID: 14530752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-modulation of granulocyte macrophage-colony stimulating factor receptor on monocytes during human septic shock.
    Pangault C; Le Tulzo Y; Tattevin P; Guilloux V; Bescher N; Drénou B
    Crit Care Med; 2006 Apr; 34(4):1193-201. PubMed ID: 16484916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monocyte anergy in septic shock is associated with a predilection to apoptosis and is reversed by granulocyte-macrophage colony-stimulating factor ex vivo.
    Williams MA; Withington S; Newland AC; Kelsey SM
    J Infect Dis; 1998 Nov; 178(5):1421-33. PubMed ID: 9780264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of in vivo administration of GM-CSF and G-CSF on monocyte cytotoxicity.
    Wiltschke C; Krainer M; Wagner A; Linkesch W; Zielinski CC
    Exp Hematol; 1995 May; 23(5):402-6. PubMed ID: 7536681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo effect of recombinant human granulocyte colony-stimulating factor on phagocytic function and oxidative burst activity in septic neutropenic neonates.
    Ahmad M; Fleit HB; Golightly MG; La Gamma EF
    Biol Neonate; 2004; 86(1):48-54. PubMed ID: 15057022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between serum macrophage colony-stimulating factor levels and monocyte and thrombocyte counts in healthy, hypoxic, and septic term neonates.
    Oren H; Duman N; Abacioglu H; Ozkan H; Irken G
    Pediatrics; 2001 Aug; 108(2):329-32. PubMed ID: 11483796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.